Adenosine-induced atrial fibrillation. 1996

A J Silverman, and C Machado, and J J Baga, and M D Meissner, and M H Lehmann, and R T Steinman
Department of Internal Medicine, Wayne State University, Detroit, MI, USA.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000241 Adenosine A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. Adenocard,Adenoscan
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D001281 Atrial Fibrillation Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation. Auricular Fibrillation,Familial Atrial Fibrillation,Paroxysmal Atrial Fibrillation,Persistent Atrial Fibrillation,Atrial Fibrillation, Familial,Atrial Fibrillation, Paroxysmal,Atrial Fibrillation, Persistent,Atrial Fibrillations,Atrial Fibrillations, Familial,Atrial Fibrillations, Paroxysmal,Atrial Fibrillations, Persistent,Auricular Fibrillations,Familial Atrial Fibrillations,Fibrillation, Atrial,Fibrillation, Auricular,Fibrillation, Familial Atrial,Fibrillation, Paroxysmal Atrial,Fibrillation, Persistent Atrial,Fibrillations, Atrial,Fibrillations, Auricular,Fibrillations, Familial Atrial,Fibrillations, Paroxysmal Atrial,Fibrillations, Persistent Atrial,Paroxysmal Atrial Fibrillations,Persistent Atrial Fibrillations

Related Publications

A J Silverman, and C Machado, and J J Baga, and M D Meissner, and M H Lehmann, and R T Steinman
July 2000, Journal of cardiovascular electrophysiology,
A J Silverman, and C Machado, and J J Baga, and M D Meissner, and M H Lehmann, and R T Steinman
May 1984, The American journal of cardiology,
A J Silverman, and C Machado, and J J Baga, and M D Meissner, and M H Lehmann, and R T Steinman
June 2013, Circulation. Arrhythmia and electrophysiology,
A J Silverman, and C Machado, and J J Baga, and M D Meissner, and M H Lehmann, and R T Steinman
January 2020, Journal of cardiovascular electrophysiology,
A J Silverman, and C Machado, and J J Baga, and M D Meissner, and M H Lehmann, and R T Steinman
January 2000, Pacing and clinical electrophysiology : PACE,
A J Silverman, and C Machado, and J J Baga, and M D Meissner, and M H Lehmann, and R T Steinman
September 2015, Interactive cardiovascular and thoracic surgery,
A J Silverman, and C Machado, and J J Baga, and M D Meissner, and M H Lehmann, and R T Steinman
March 2014, Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing,
A J Silverman, and C Machado, and J J Baga, and M D Meissner, and M H Lehmann, and R T Steinman
February 1997, Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing,
A J Silverman, and C Machado, and J J Baga, and M D Meissner, and M H Lehmann, and R T Steinman
May 2008, Journal of cardiovascular electrophysiology,
A J Silverman, and C Machado, and J J Baga, and M D Meissner, and M H Lehmann, and R T Steinman
January 2012, Cardiology journal,
Copied contents to your clipboard!